Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Ethanol combined with heparin as a locking solution for the prevention of catheter related blood stream infections in hemodialysis patients: A prospective randomized study.

Sofroniadou S, Revela I, Kouloubinis A, Makriniotou I, Zerbala S, Smirloglou D, Kalocheretis P, Drouzas A, Samonis G, Iatrou C.

Hemodial Int. 2017 Oct;21(4):498-506. doi: 10.1111/hdi.12524. Epub 2017 Jan 11.

PMID:
28078825
2.

The role of TNF-α, Fas/Fas ligand system and NT-proBNP in the early detection of asymptomatic left ventricular dysfunction in cancer patients treated with anthracyclines.

Kouloubinis A, Sofroniadou S, Panoulas VF, Makaritsis K, Revela I, Karavolias G, Voudris V, Adamopoulos S.

Int J Cardiol Heart Vasc. 2015 Jan 9;6:85-90. doi: 10.1016/j.ijcha.2015.01.002. eCollection 2015 Mar 1.

3.

Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis.

Sofroniadou S, Kassimatis T, Srirajaskanthan R, Reidy J, Goldsmith D.

Int Urol Nephrol. 2012 Oct;44(5):1451-9. doi: 10.1007/s11255-011-0091-y. Epub 2011 Nov 30.

PMID:
22127407
4.

Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study.

Sofroniadou S, Revela I, Smirloglou D, Makriniotou I, Zerbala S, Kouloubinis A, Samonis G, Iatrou C.

Semin Dial. 2012 May;25(3):344-50. doi: 10.1111/j.1525-139X.2011.00965.x. Epub 2011 Nov 10.

PMID:
22074188
5.

Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects.

Sofroniadou S, Goldsmith D.

Drug Saf. 2011 Feb 1;34(2):97-115. doi: 10.2165/11585040-000000000-00000.

PMID:
21247219
6.

Anaemia, microcytosis and sirolimus--is iron the missing link?

Sofroniadou S, Kassimatis T, Goldsmith D.

Nephrol Dial Transplant. 2010 May;25(5):1667-75. doi: 10.1093/ndt/gfp674. Epub 2010 Jan 6.

PMID:
20054028
7.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450.

8.

ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.

Kouloubinis A, Kaklamanis L, Ziras N, Sofroniadou S, Makaritsis K, Adamopoulos S, Revela I, Athanasiou A, Mavroudis D, Georgoulias V.

Int J Cardiol. 2007 Nov 30;122(3):195-201. Epub 2007 Feb 7.

PMID:
17289172
9.

Absence of chemotherapy-induced alopecia with paclitaxel in a case of hypothyroidism: case report.

Sofroniadou S, Kosmas C, Kourelis T, Makatsoris T, Koutras A, Onienadoum A, Kalofonos HP.

Ann Oncol. 2003 Nov;14(11):1690-1. No abstract available.

PMID:
14581281

Supplemental Content

Loading ...
Support Center